These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Fletcher CD; Akerman M; Dal Cin P; de Wever I; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van den Berghe H; van de Ven W; Vanni R; Willen H Am J Pathol; 1996 Feb; 148(2):623-30. PubMed ID: 8579124 [TBL] [Abstract][Full Text] [Related]
11. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses. Iwasaki H; Ishiguro M; Nishio J; Aoki M; Yokoyama R; Yokoyama K; Taguchi K; Nabeshima K Virchows Arch; 2015 Apr; 466(4):453-64. PubMed ID: 25650275 [TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas. Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis. Creytens D; Van Gorp J; Speel EJ; Ferdinande L Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836 [TBL] [Abstract][Full Text] [Related]
14. Vulvar Myxoid Liposarcoma and Well Differentiated Liposarcoma With Molecular Cytogenetic Confirmation: Case Reports With Review of Malignant Lipomatous Tumors of the Vulva. Schoolmeester JK; Leifer AJ; Wang L; Hameed MR Int J Gynecol Pathol; 2015 Jul; 34(4):390-5. PubMed ID: 25851712 [TBL] [Abstract][Full Text] [Related]
15. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the "missing link" between lipomas and liposarcomas? Italiano A; Cardot N; Dupré F; Monticelli I; Keslair F; Piche M; Mainguené C; Coindre JM; Pedeutour F Int J Cancer; 2007 Jul; 121(2):308-15. PubMed ID: 17372913 [TBL] [Abstract][Full Text] [Related]
16. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma. Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281 [TBL] [Abstract][Full Text] [Related]
17. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3. Mrózek K; Karakousis CP; Bloomfield CD Cancer Res; 1993 Apr; 53(7):1670-5. PubMed ID: 8453640 [TBL] [Abstract][Full Text] [Related]
18. Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma. Schoenmakers EF; Kools PF; Mols R; Kazmierczak B; Bartnitzke S; Bullerdiek J; Dal Cin P; De Jong PJ; Van den Berghe H; Van de Ven WJ Genomics; 1994 Mar; 20(2):210-22. PubMed ID: 8020967 [TBL] [Abstract][Full Text] [Related]
19. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma. Rivero ER; Mesquita RA; de Sousa SC; Nunes FD Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544 [TBL] [Abstract][Full Text] [Related]
20. Benign recurring lipoblastoma in an adult versus well differentiated subcutaneous myxoid liposarcoma: clinicopathologic, immunohistochemical and molecular analysis of a unique case. Silverman JS; Hamilton J; Tamsen A Pathol Res Pract; 1999; 195(11):787-92; discussion 793. PubMed ID: 10605700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]